Health Care • Hospital/Nursing Management
$131.49 ▲ +9.40
(+7.70%)
MKT CAP: $12.97B • VOL: 2.20M
52W L $93 52W H $137
EHC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.94B | $5.37B | $4.80B |
| YoY Revenue Growth % | +10.5% | +11.9% | — |
| Gross Profit | $2.61B | $2.36B | $2.11B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $668.1M | $537.7M | $415.4M |
| Operating Margin % | 11.3% | 10.0% | 8.7% |
| Net Income (GAAP) | $566.2M | $455.7M | $352.0M |
| EBITDA (Normalized) | $881.8M | $731.2M | $588.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $634.1M | $510.4M | $394.2M |
| Capital Expenditures (CapEx) | $267.1M | $241.8M | $216.1M |
| Free Cash Flow (FCF) | $367.1M | $268.6M | $178.2M |
| FCF Margin % | 6.2% | 5.0% | 3.7% |
| Return on Invested Capital (ROIC %) | 12.9% | 11.7% | 7.6% |
| Cash & Short-Term Equivalents | $72.2M | $85.4M | $784.8M |
| Total Debt (Short + Long Term) | $1.72B | $1.66B | $1.67B |
| Total Stockholders' Equity | $2.44B | $2.07B | $3.42B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR EHC.